Jean-Paul Thiery

22PUBLICATIONS
85CO-AUTHORS
Cancer cell biologyMechanobiologyMolecular targetsPredictive and prognostic markersTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 27, 2026
Recurrence in the chemotherapy regimen of bladder carcinoma originates from quiescent epidermoid-like cells.

|Feb 01, 2024
How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine.

Jean Paul Thiery, Guojun Sheng, Xiaodong Shu

|Dec 15, 2023
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam

|Mar 20, 2023
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.

Lei Zhang, Yuqing Li, Lingli Zhou

|Jul 25, 2022
PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signaling.

Jean Agnetti, Vanessa Bou Malham, Christophe Desterke

|Apr 15, 2022
The Continuing Search for Causality between Epithelial-to-Mesenchymal Transition and the Metastatic Fitness of Carcinoma Cells.

Valerie S LeBleu, Jean Paul Thiery

Pageof 4

Frequent Collaborators

7 joint publications

Tuan Zea Tan

3 joint publications

Pieter Johan Adam Eichhorn

3 joint publications

Raymond Runyan

3 joint publications

Alan Prem Kumar